Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Opie

Showing results (1-10 of 423) with videos related to

Pageof 43
Sort By:
American Heart Journal|March 1, 1979
Role of carnitine in fatty acid metabolism of normal and ischemic myocardiumL H Opie
Lancet (London, England)|October 7, 1995
Risks and benefits of calcium antagonistsL H Opie
Progress in Cardiovascular Diseases|January 1, 1996
Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical useL H Opie
Basic Research in Cardiology|July 1, 1995
Chronic stunning: the new switch in thoughtL H Opie
American Heart Journal|May 1, 1975
Dietary sucrose in relation to the development of ischemic heart diseaseL H Opie
Lancet (London, England)|August 25, 1999
Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium?L H Opie
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 9, 2000
Cardiac metabolism in ischemic heart diseaseL H Opie
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 1, 1996
ACE inhibitors in pregnancy--how to avoid the sting in the tailL H Opie
Cardiovascular Research|August 1, 1992
Cardiac metabolism--emergence, decline, and resurgence. Part IL H Opie
The Quarterly Journal of Medicine|January 1, 1984
Calcium antagonists. Mechanisms, therapeutic indications and reservations: a reviewL H Opie
Pageof 43

Showing results (1-10 of 423) with videos related to

Sort By:
Pageof 43
American Heart Journal|March 1, 1979
Role of carnitine in fatty acid metabolism of normal and ischemic myocardiumL H Opie
Lancet (London, England)|October 7, 1995
Risks and benefits of calcium antagonistsL H Opie
Progress in Cardiovascular Diseases|January 1, 1996
Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical useL H Opie
Basic Research in Cardiology|July 1, 1995
Chronic stunning: the new switch in thoughtL H Opie
American Heart Journal|May 1, 1975
Dietary sucrose in relation to the development of ischemic heart diseaseL H Opie
Lancet (London, England)|August 25, 1999
Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium?L H Opie
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 9, 2000
Cardiac metabolism in ischemic heart diseaseL H Opie
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 1, 1996
ACE inhibitors in pregnancy--how to avoid the sting in the tailL H Opie
Cardiovascular Research|August 1, 1992
Cardiac metabolism--emergence, decline, and resurgence. Part IL H Opie
The Quarterly Journal of Medicine|January 1, 1984
Calcium antagonists. Mechanisms, therapeutic indications and reservations: a reviewL H Opie
Pageof 43